Teva Pharmaceutical Industries Limited Share Price
Stocks
TEVA
US8816242098
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.26 USD | -2.72% |
|
-3.98% | +6.57% |
| Capitalization | 3.87TCr 0 0 0 0 0 0 0 0 0 0 0 0 | P/E ratio 2026 * |
29.9x | P/E ratio 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 4.97TCr 0 0 0 0 0 0 0 0 0 0 0 0 | EV / Sales 2026 * |
2.99x | EV / Sales 2027 * | 2.71x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -2.72% | ||
| 1 week | -3.98% | ||
| Current month | -5.83% | ||
| 1 month | -6.91% | ||
| 3 months | +7.12% | ||
| 6 months | +17.40% | ||
| Current year | +6.57% |
| 1 week | 32.37 |  | 35.01 |
| 1 month | 32.37 | | 36.43 |
| Current year | 27.93 | | 37.34 |
| 1 year | 14.99 | | 37.34 |
| 3 years | 7.27 | | 37.34 |
| 5 years | 6.78 | | 37.34 |
| 10 years | 6.07 | | 56.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06 | Fiscal year | Chief Operating Officer | 48,585 | 0.0042% | ||
| 28/05 | Free | Director | 7,242 | 0.0006% | ||
| 28/05 | Free | Director | 7,242 | 0.0006% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.72% | -3.98% | +87.17% | +350.07% | 3.98TCr | |
| +1.57% | +6.19% | +49.26% | +157.85% | 1,00900Cr | |
| -0.26% | +3.87% | +49.75% | +44.86% | 56TCr | |
| -1.83% | +4.76% | +17.51% | +62.07% | 40TCr | |
| +0.77% | +3.06% | +21.96% | +15.20% | 33TCr | |
| -1.05% | +3.78% | +51.35% | +8.34% | 30TCr | |
| -0.45% | +2.69% | +27.95% | +17.41% | 29TCr | |
| -0.54% | +3.02% | +20.87% | +29.84% | 27TCr | |
| -4.17% | -4.53% | -44.53% | -50.50% | 19TCr | |
| -1.10% | +5.04% | +19.08% | +56.61% | 19TCr | |
| Average | -0.98% | +2.22% | +30.04% | +69.18% | 35.79TCr | |
| Weighted average by Cap. | -0.21% | +3.75% | +33.32% | +68.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.67TCr 0 0 0 0 0 0 0 0 0 0 0 0 | 1.73TCr 0 0 0 0 0 0 0 0 0 0 0 0 |
| Net income | 176.26Cr 0 0 0 0 0 0 0 0 0 0 0 0 | 266.26Cr 0 0 0 0 0 0 0 0 0 0 0 0 |
| Net Debt | 1.1TCr 0 0 0 0 0 0 0 0 0 0 0 0 | 800.78Cr 0 0 0 0 0 0 0 0 0 0 0 0 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | 33.26 $ | -2.72% | 57,50,525 |
| 05/26/05 | 34.19 $ | -0.70% | 57,13,369 |
| 04/26/04 | 34.43 $ | +4.87% | 55,75,695 |
| 03/26/03 | 32.83 $ | -0.76% | 50,70,028 |
| 02/26/02 | 33.08 $ | -4.50% | 1,02,82,222 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition